silodosin (Rapaflo)

From Aaushi
Jump to navigation Jump to search

Introduction

FDA approved Oct 2008

Indications

Contraindications

Dosage

8 mg QD

Tabs: 4 mg, 8 mg Dosage adjustment in renal impairment:

Adverse effects

Mechanism of action

More general terms

References

  1. FDA News FDA Approves Rapaflo for the Treatment of Symptoms Due to an Enlarged Prostate Gland http://www.fda.gov/bbs/topics/NEWS/2008/NEW01902.html
  2. Prescriber's Letter 16(5) 2009 Comparison of Alpha1-Blockers Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=250505&pb=PRL (subscription needed) http://www.prescribersletter.com
  3. 3.0 3.1 Deprecated Reference